BioNTech SE Investor
At BioNTech we understand that every cancer patient’s tumor is unique and therefore each patient’s treatment should be individualized.
Industry:
Genomic and Epigenominc Instabillity
Headquarters:
Mainz, Rheinland-Pfalz, Germany